Public filings / DFTX on Yahoo Finance (opens in a new tab)
DFTX: insider buying, 13F holders, analyst moves
Definium Therapeutics Inc
A summary of public filings about Definium Therapeutics Inc. For the latest insider history, price chart, analyst changes and activist filings, open the live lookup.
SEC Form 13F · Q2 2026
5 of our 100 managers hold DFTX
Combined reported value $573.7M.
Holders among our 100 managers: 0 in Q3 2023, 5 in Q2 2026.
| Manager | Value | % of portfolio | Change vs Q1 2026 |
|---|---|---|---|
| Avoro Capital Advisors | $338.2M | 3.04% | Added |
| Deep Track Capital | $129.4M | 1.91% | Trimmed |
| RA Capital | $70.6M | 0.61% | New |
| RTW Investments | $18.8M | 0.16% | Added |
| Duquesne Family Office | $16.8M | 0.39% | New |
Important information
Facts from public SEC filings, shown for information only. Not a recommendation. Not individualized investment advice. Gulfstream Capital and its clients may hold positions in securities shown.